| Jonah Kirkwood |
Jonah Kirkwood is currently working as the Chief Commercial Officer at Agilent Technologies, Inc. |
| Katharine Knobil |
Presently, Katharine Knobil occupies the position of Chief Medical Officer for Agilent Technologies, Inc. Dr. Knobil is also on the board of Marker Therapeutics, Inc. and Pliant Therapeutics, Inc. and Member of The National Academies of Science.
In the past she occupied the position of Chief Medical Officer, Head-Research & Development at Kaleido Biosciences, Inc. and Chief Medical Officer & Senior Vice President of GlaxoSmithKline LLC.
Dr. Knobil received an undergraduate degree from Cornell University and a doctorate from The University of Texas Southwestern Medical Center. |
| Darlene J. S. Solomon |
Darlene J. S. Solomon occupies the position of Chief Technology Officer & Senior Vice President at Agilent Technologies, Inc. She is also on the board of Novanta, Inc. and Materion Corp. and Member of National Academy of Engineering.
She previously was Director & Vice President at Agilent Laboratories, Inc., Chief Technology Officer & Vice President at Keysight Technologies UK Ltd., Manager-Research & Development at Hewlett-Packard Laboratories and Chairman-Research & Development at Blue Ribbon Task Force on Nanotechnology.
She received an undergraduate degree from Stanford University and a doctorate from Massachusetts Institute of Technology. |
| Padraig Mcdonnell |
Padraig Mcdonnell is currently the CEO-Elect & Chief Operating Officer at Agilent Technologies, Inc. Prior to this, he worked at the National University of Ireland. He is a graduate of the National University of Ireland. |
| John Kohl |
John Kohl is currently the Chief Information Officer & Senior Vice President at Agilent Technologies, Inc. He obtained an undergraduate degree from the University of Arizona. |
| Robert W. McMahon |
Robert W. McMahon is an Independent Director at OraSure Technologies, Inc. since 2023 and the Chief Financial Officer & Senior Vice President at Agilent Technologies, Inc. since 2018. Previously, he served as the Chief Financial Officer at Hologic, Inc. from 2014 to 2018, the Vice President-Finance & Business Development at Ortho-Clinical Diagnostics, Inc. from 2011 to 2014, and the Vice President-Finance & Business Development at Johnson & Johnson, Inc. from 1993 to 2014. He holds an MBA from the University of Central Florida and an undergraduate degree from the University of Florida. |
| Rodney Gonsalves |
Rodney Gonsalves is currently the Chief Accounting Officer, VP & Controller at Agilent Technologies, Inc. He completed his undergraduate degree at California State University-Fresno and his MBA at Santa Clara University. |
| Boon Hwee Koh |
Boon Hwee Koh founded Altara Ventures Pte Ltd. in 2006, where he is working as Chairman & General Partner from 2006. Mr. Koh also founded Gnowbe Pte Ltd. Mr. Koh also currently works at Agilent Technologies, Inc., as Non-Executive Chairman from 2017, Singapore Exchange Ltd., as Chairman from 2023, Sunningdale Tech Ltd., as Non-Executive Chairman from 2009, and various other companies. Mr. Koh also formerly worked at DBS Group Holdings Ltd., as Chairman & Chief Executive Officer from 2009 to 2010, Singapore Telecommunications Ltd., as Chairman from 1992 to 2001, SIA Engineering Co. Ltd., as Chairman from 2003 to 2005, and various other companies. Mr. Koh received his undergraduate degree in 1972 from Imperial College London and Masters Business Admin degree in 1976 from Harvard Business School. |
| Samraat S Raha |
Samraat S Raha is SVP & President-Diagnostic & Genomics Group at Agilent Technologies, Inc.
In the past he held the position of Vice President-Global Marketing at Illumina, Inc., Chief Executive Officer of Joby, Inc. and Vice President & GM-Genomic Assays & NextGen qPCR at Life Technologies, Inc.
Samraat S Raha received an undergraduate degree from the University of California, Berkeley and an MBA from Santa Clara University. |
| Michael R. McMullen |
Michael R. McMullen is currently the President, Chief Executive Officer & Director at Agilent Technologies, Inc. since 2015. He is also an Independent Director at KLA Corp. starting in 2023. Previously, he served as an Independent Director at Coherent, Inc. from 2018 to 2022. Prior to that, he held the position of Treasurer, Senior Vice President & Controller at HP, Inc. from 1984 to 2013. Additionally, he worked as a Controller at Yokogawa-Hewlett-Packard Ltd. from 1996 to 1999. Mr. McMullen obtained his undergraduate degree from the University of Delaware and an MBA from The Wharton School of the University of Pennsylvania in 1988. |
| Angelica Riemann |
Angelica Riemann is currently the President-Agilent CrossLab Group at Agilent Technologies, Inc. |
| L. William Krause |
L. William Krause is currently the Chairman at Veritas Holdings Ltd. and the Director at Commscope, Inc. He is also an Independent Director at CommScope Holding Co., Inc., and holds director positions at Aureal Semiconductor, Inc., CommScope, Inc. of North Carolina, Forward Networks, Inc., Veritas Technologies LLC (California), and Smartcar, Inc. Additionally, he is the President of LWK Ventures and a Board Partner at AH Capital Management LLC. In the past, Mr. Krause served as the President & Chief Executive Officer of Storm Technology, Inc. He was also the Chairman & Chief Executive Officer of Exodus Communications, Inc. and the Chairman of 3com Corp. (Massachusetts). He held the position of Chairman at Caspian Networks, Inc. and served as an Independent Director at Coherent, Inc. for 10 years. Furthermore, he was a Director at Sybase, Inc., Brocade Communications Systems LLC, Core-Mark Holding Co. LLC, Packeteer, Inc., and CPU Technology, Inc. He also served as an Independent Director at Power Assure, Inc. and The Trizetto Group, Inc., and as an Operating Executive at The Carlyle Group LP (Corporate Private Equity). Mr. Krause obtained his undergraduate degree from The Citadel, The Military College of South Carolina. |
| Jacob Thaysen |
Jacob Thaysen is on the board of Gen9, Inc. and Lasergen, Inc. and SVP & President-Life Sciences & Applied Markets at Agilent Technologies, Inc.
In the past Dr. Thaysen held the position of Chief Technology Officer & Founding Partner at Cantion A, Vice President-Research & Development of Cytologix Corp. and Vice President & General Manager at Dako Denmark ApS.
Jacob Thaysen received a doctorate and a graduate degree from Technical University of Denmark. |
| Sue H. Rataj |
Sue H. Rataj is currently an Independent Director at Cabot Corp. since 2018 and at Agilent Technologies, Inc. since 2015. Previously, she served as the Chief Executive Officer-Petrochemicals at BP Plc from 2008 to 2011, as a Member-Supervisory Board at Bayer AG from 2012 to 2017, and as the President at PTA Global, Inc. in 2004 and 2005. Ms. Rataj completed her undergraduate studies at the University of Illinois and earned an MBA from Kellogg School of Management in 1988. |
| Hans Edgar Bishop |
Hans Edgar Bishop is the founder of Juno Therapeutics, Inc. (founded in 2013), Sana Biotechnology, Inc. (founded in 2018), and Altos Labs, Inc. (founded in 2021). He currently holds positions as an Independent Director at Agilent Technologies, Inc. (since 2017), Director at JW Biotechnology (Shanghai) Co. Ltd. and JW Therapeutics (Shanghai) Co., Ltd., Independent Director at Lyell Immunopharma, Inc. (since 2018), and Director at Ophirex, Inc. (since 2020). He previously held positions as Chief Executive Officer & Director at GRAIL LLC (2016-2021), Executive Chairman at Iovance Biotherapeutics, Inc. (2012), Director at Celgene Corp. (2018-2019), Independent Director at Avanir Pharmaceuticals, Inc. (2012-2015), President & Director at X-Body, Inc., Non-Executive Director at JW (Cayman) Therapeutics Co. Ltd. (2017-2021), Senior Vice President-Global Commercial Operations at Chiron Corp. (2004-2006), Executive-in-Residence at Warburg Pincus LLC, Principal at Glaxo Wellcome Plc and GlaxoSmithKline LLC, Chief Operating Officer & Executive Vice President at Dendreon Corp. (2010-2011) and PhotoThera, Inc. (2012), and President-Specialty Medicine Business at Bayer HealthCare Pharmaceuticals, Inc. (2006-2010). He received his undergraduate degree from Brunel University in 1987. |
| Dow R. Wilson |
Dow R. Wilson is currently an Independent Director at Agilent Technologies, Inc., a Director at the Advanced Medical Technology Association, a Director at Siemens Healthineers AG, and a Director at the US India Strategic Partnership Forum. Previously, he served as the CEO-Patient Monitoring Technologies at GE Aerospace. From 2020 to 2021, he was the Chief Executive Officer & Director at Varian Medical Systems, Inc. He also held the position of Chief Executive Officer at General Electric Information Services from 2003 to 2005 and at GE Healthcare IVD Technologies from 2000 to 2005. Additionally, he was the Chairman of the United States-Brazil CEO Forum. From 2012 to 2015, he served as the Lead Independent Director at Saba Software, Inc. He was a Director at Varex Imaging Corp. from 2017 to 2018 and President & Executive Vice President-Corporate at Oncology Systems Ltd. from 2005 to 2011. Mr. Wilson received his undergraduate degree from Brigham Young University and his MBA from the Tuck School of Business at Dartmouth. |
| George A. Scangos |
George A. Scangos is the founder of Rezo Therapeutics, Inc. (founded in 2022) where he holds the title of Chairman. He is currently the Vice Chairman at Fondation Santé since 2011 and an Independent Director at Agilent Technologies, Inc. since 2011. He is also a Director at Biomedical Sciences Careers Program, Inc., Voyager Therapeutics, Inc. (since 2023), Octave Bioscience, Inc. (since 2018), Vir Biotechnology, Inc. (since 2017), and ARCH Venture Partners LLC. Additionally, he serves as a Trustee at Cornell University, an Analyst at IS. Yatirim Menkul Degerler. AS (Broker), a Member-National Board of Visitors at UC Davis School of Medicine, a Member-Overseers Board at the University of California, and a Trustee at Life Science Cares, Inc.Dr. Scangos's former positions include being the Chief Executive Officer & Director at Biogen, Inc. (2010-2017), Chief Executive Officer at Biogen Idec New Ventures, Inc., Chief Executive Officer at Biogen Idec, Inc. (North Carolina) (2010-2017), Chairman at Anadys Pharmaceuticals, Inc. (2003-2010), Chairman at Pharmaceutical Research & Manufacturers of America (2016-2017), Chairman at California Healthcare Institute, Director at Onyx Pharmaceuticals, Inc. (2000-2005), Director at Exelixis, Inc. (2010-2020), Non-Executive Director at Entelos, Inc. (1997-2010), Director at Global Alliance for TB Drug Development (2006-2010), President-Biotechnology Division at Bayer Corp. (1993-1996), Senior Vice President-Research & Development at Bayer, Inc. (1987-1996), President at Bayer Biotechnology (1993-1996), and Professor at The Johns Hopkins University. He has also served as a Director at Taconic Biosciences GmbH, Symphony Evolution, Inc., Baybio Institute, and Decibel Therapeutics, Inc. Furthermore, he has been a Trustee at the Museum of Science. Dr. Scangos's education includes an undergraduate degree from Cornell University and a doctorate degree from the University of Massachusetts. |
| Otis W. Brawley |
Otis W. Brawley is an Independent Director at Incyte Corp., Agilent Technologies, Inc., PDS Biotechnology Corp., and Lyell Immunopharma, Inc. He is also a Professor of Oncology & Epidemiology at The Johns Hopkins University. He previously served as a Director at Theragenics Corp., Director at Georgia Cancer Center, Director at The National Coalition For Cancer Research, Chief Medical & Scientific Officer at American Cancer Society, Inc., and Professor at Emory University School of Medicine. Brawley is an undergraduate alumnus of The University of Chicago and holds a doctorate from Pritzker School of Medicine. |
| Daniel K. Podolsky |
Daniel K. Podolsky is the founder of The Gi Co., Inc. He currently serves as an Independent Director at Agilent Technologies, Inc., Director at Southwestern Medical Foundation, Member of the National Academy of Sciences, Member of the National Academy of Medicine (United States), and Member of the Council of Teaching Hospitals. He also serves as the President of The University of Texas Southwestern Medical Center. In the past, he has served as an Independent Non-Executive Director at Genelabs Technologies, Inc., Independent Non-Executive Director at GSK Plc, Director at Antibe Therapeutics, Inc., Chief Gastroenterology at The General Hospital Corp., Chief Academic Officer & Dean at Mass General Brigham, Inc., President of the American Gastroenterological Association, and Professor at Harvard Medical School. He holds a doctorate degree from Harvard University. |
| Mala Anand |
Mala Anand currently works at Agilent Technologies, Inc., as Independent Director from 2019, Cotiviti Holdings, Inc., as Independent Director from 2016, and Microsoft Corp., as Vice President-Customer Experience & Success from 2019. Ms. Anand also formerly worked at Cisco Systems, Inc., as SVP-Data & Analytics, Automation Software Platform from 2014 to 2016, SAP SE, as President-Intelligent Enterprise Solutions from 2016 to 2019, Informative, Inc., as Chief Operating Officer, SVP-Products & Services, CoroSoft Technologies, Inc., as Vice President-Products & Technology, and Rapt Technologies, Inc., as Vice President-Technology & Product Development. Ms. Anand received her graduate degree from Brown University and undergraduate degree from the University of Massachusetts. |
| Mikael Dolsten |
Mikael Dolsten is currently an Independent Director at Agilent Technologies, Inc., a Director at Research!America, a Director at PhRMA Foundation, and an Independent Director at Vimian Group AB. He is also the Co-Chief Scientific Officer & President-Research at Pfizer Inc. since 2019. In addition, he serves as a Member of the Overseers Board at The Scripps Research Institute, a Member of the Governors Board at New York Academy of Sciences, a Member of the Royal Swedish Academy of Engineering Sciences, and a Member of the Government-University-Industry Research Roundtable. Previously, Dr. Dolsten was an Independent Director at Karyopharm Therapeutics, Inc. from 2015 to 2021. He also held the position of Senior Vice President at Wyeth LLC from 2008 to 2009. He served as a Global Vice President at AstraZeneca PLC and as a Principal at OrbiMed Advisors LLC in 2008. Additionally, he was a Senior Vice President at Wyeth Pharmaceuticals LLC from 2008 to 2009. Prior to that, he was the Executive VP & Head of Worldwide Research at Boehringer Ingelheim Pharmaceuticals, Inc. from 2003 to 2008. He also held positions as President at Wyeth Research in 2008 and as a Partner at OrbiMed Advisors Private Equity in 2008. Dr. Dolsten obtained a doctorate degree from the University of Lund. |
| Heidi Kunz Fields |
Heidi Kunz Fields is an Independent Director at Agilent Technologies, Inc. and Phathom Pharmaceuticals, Inc. She previously served as Director at Financial Engines, Inc., Independent Director at Avanos Medical, Inc., and Independent Director at Icosavax, Inc. She was also the Chief Financial Officer & Executive Vice President at Gap, Inc., Treasurer & Vice President at General Motors Corp., Chief Financial Officer & Executive Vice President at Blue Shield of California, and Chief Financial Officer at ITT Industries, Inc. Ms. Fields received her undergraduate degree from Georgetown University and her MBA from Columbia Business School. |
